Stockreport

Moleculin Receives First Country Approval in Europe to Begin Recruiting for the MIRACLE Phase 3 R/R Acute Myeloid Leukemia (AML) Pivotal Trial [Yahoo! Finance]

Moleculin Biotech, Inc.  (MBRX) 
Last moleculin biotech, inc. earnings: 8/16 05:35 pm Check Earnings Report
US:NASDAQ Investor Relations: moleculin.com/investors
PDF PR Newswire Tue, February 11, 2025 at 2:40 PM GMT+1 6 min read In This Article MBRX First of many site approvals, including sites in the US, Europe and the Mi [Read more]